Variant · Snv
VMA12 NM_152464.3(VMA12):c.472G>A (p.Val158Ile)
CI-VAR-00127228Explore in graph →p.Val158IleNM_152464.3:c.472G>AClinVar 783775 rs12572
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 783775 | Benign | criteria provided, multiple submitters, no conflicts | 2 | TMEM199-related disorder; Ovarian serous cystadenocarcinoma; Uterine carcinosarcoma; Thymoma; Thyroid cancer, nonmedullary, 1; Uterine corpus endometrial carcinoma; Gastric cancer; Cholangiocarcinoma; Hepatocellular carcinoma; Clear cell carcinoma of kidney; Acute myeloid leukemia; Cervical cancer | germline | 5 | Feb 01, 2026 | clinvar |